Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma

ConclusionsOur findings demonstrate the potential value of MerTK as a prognostic biomarker for gastric adenocarcinoma. Targeting MerTK may become a new treatment option, especially for patients with advanced tumors, and may overcome resistance to established chemotherapies.

https://onlinelibrary.wiley.com/doi/10.1002/cam4.6866?af=R

Source: Cancer Medicine - March 28, 2024 Category: Cancer & Oncology Authors: Naita Maren Wirsik, Mingyi Chen, Liping He, Uraz Yasar, Justus Gaukel, Alexander Quaas, Henrik Nienh üser, Ella Leugner, Shuai Yuan, Nikolai Schleussner, Jin‐On Jung, Jadie Sue Plücker, Martin Schneider, Thomas Schmidt Tags: RESEARCH ARTICLE Source Type: research